Literature DB >> 35896766

Processed Electroencephalogram-Based Monitoring to Guide Sedation in Critically Ill Adult Patients: Recommendations from an International Expert Panel-Based Consensus.

Frank A Rasulo1,2, Philip Hopkins3, Francisco A Lobo4, Pierre Pandin5, Basil Matta6, Carla Carozzi7, Stefano Romagnoli8, Anthony Absalom9, Rafael Badenes10, Thomas Bleck11, Anselmo Caricato12, Jan Claassen13, André Denault14, Cristina Honorato15, Saba Motta16, Geert Meyfroidt17, Finn Michael Radtke18, Zaccaria Ricci19, Chiara Robba20, Fabio S Taccone5, Paul Vespa21, Ida Nardiello22, Massimo Lamperti4.   

Abstract

BACKGROUND: The use of processed electroencephalography (pEEG) for depth of sedation (DOS) monitoring is increasing in anesthesia; however, how to use of this type of monitoring for critical care adult patients within the intensive care unit (ICU) remains unclear.
METHODS: A multidisciplinary panel of international experts consisting of 21 clinicians involved in monitoring DOS in ICU patients was carefully selected on the basis of their expertise in neurocritical care and neuroanesthesiology. Panelists were assigned four domains (techniques for electroencephalography [EEG] monitoring, patient selection, use of the EEG monitors, competency, and training the principles of pEEG monitoring) from which a list of questions and statements was created to be addressed. A Delphi method based on iterative approach was used to produce the final statements. Statements were classified as highly appropriate or highly inappropriate (median rating ≥ 8), appropriate (median rating ≥ 7 but < 8), or uncertain (median rating < 7) and with a strong disagreement index (DI) (DI < 0.5) or weak DI (DI ≥ 0.5 but < 1) consensus.
RESULTS: According to the statements evaluated by the panel, frontal pEEG (which includes a continuous colored density spectrogram) has been considered adequate to monitor the level of sedation (strong consensus), and it is recommended by the panel that all sedated patients (paralyzed or nonparalyzed) unfit for clinical evaluation would benefit from DOS monitoring (strong consensus) after a specific training program has been performed by the ICU staff. To cover the gap between knowledge/rational and routine application, some barriers must be broken, including lack of knowledge, validation for prolonged sedation, standardization between monitors based on different EEG analysis algorithms, and economic issues.
CONCLUSIONS: Evidence on using DOS monitors in ICU is still scarce, and further research is required to better define the benefits of using pEEG. This consensus highlights that some critically ill patients may benefit from this type of neuromonitoring.
© 2022. The Author(s).

Entities:  

Keywords:  Consensus; Critically ill; EEG; Monitoring; Sedation

Year:  2022        PMID: 35896766     DOI: 10.1007/s12028-022-01565-5

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.532


  94 in total

1.  Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.

Authors:  Judith Jacobi; Gilles L Fraser; Douglas B Coursin; Richard R Riker; Dorrie Fontaine; Eric T Wittbrodt; Donald B Chalfin; Michael F Masica; H Scott Bjerke; William M Coplin; David W Crippen; Barry D Fuchs; Ruth M Kelleher; Paul E Marik; Stanley A Nasraway; Michael J Murray; William T Peruzzi; Philip D Lumb
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

2.  Bispectral index (BIS) monitoring of acute encephalitis with refractory, repetitive partial seizures (AERRPS).

Authors:  A A Dahaba; D W Liu; H Metzler
Journal:  Minerva Anestesiol       Date:  2010-04       Impact factor: 3.051

Review 3.  Depth of anaesthesia monitoring: what's available, what's validated and what's next?

Authors:  J Bruhn; P S Myles; R Sneyd; M M R F Struys
Journal:  Br J Anaesth       Date:  2006-06-02       Impact factor: 9.166

4.  What Is Safe Sedation in the ICU?

Authors:  Douglas B Coursin; Yoanna Skrobik
Journal:  N Engl J Med       Date:  2019-06-27       Impact factor: 91.245

Review 5.  Sedation and delirium in the intensive care unit.

Authors:  Michael C Reade; Simon Finfer
Journal:  N Engl J Med       Date:  2014-01-30       Impact factor: 91.245

6.  Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.

Authors:  J P Kress; A S Pohlman; M F O'Connor; J B Hall
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

7.  Sedation in the intensive care setting.

Authors:  Christopher G Hughes; Stuart McGrane; Pratik P Pandharipande
Journal:  Clin Pharmacol       Date:  2012-10-25

8.  Bilateral Bispectral Index Monitoring Performance in the Detection of Seizures in Nonanesthetized Epileptic Patients: An Observational Study.

Authors:  Neus Fàbregas; Jose F Valencia; Isabel Belda; Ana Tercero; Adriana Hervias; Santiago Villafuerte; Pedro L Gambús; Mar Carreño; Ricard Valero
Journal:  J Neurosurg Anesthesiol       Date:  2021-06-07       Impact factor: 3.969

Review 9.  Optimizing sedation in patients with acute brain injury.

Authors:  Mauro Oddo; Ilaria Alice Crippa; Sangeeta Mehta; David Menon; Jean-Francois Payen; Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Crit Care       Date:  2016-05-05       Impact factor: 9.097

Review 10.  Analgesia and sedation in patients with ARDS.

Authors:  Gerald Chanques; Jean-Michel Constantin; John W Devlin; E Wesley Ely; Gilles L Fraser; Céline Gélinas; Timothy D Girard; Claude Guérin; Matthieu Jabaudon; Samir Jaber; Sangeeta Mehta; Thomas Langer; Michael J Murray; Pratik Pandharipande; Bhakti Patel; Jean-François Payen; Kathleen Puntillo; Bram Rochwerg; Yahya Shehabi; Thomas Strøm; Hanne Tanghus Olsen; John P Kress
Journal:  Intensive Care Med       Date:  2020-11-10       Impact factor: 17.440

View more
  1 in total

1.  Processed EEG monitoring in critical care: a black swan or a shining star?

Authors:  Francisco A Lobo; Chiara Robba; Massimo Lamperti; Stefano Romagnoli; Frank A Rasulo
Journal:  J Clin Monit Comput       Date:  2022-08-02       Impact factor: 1.977

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.